{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:59:23Z","timestamp":1792191563620,"version":"4.4.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circ: Cardiovascular Interventions"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:p>Atherosclerosis within 2 or more arterial beds has been termed polyvascular disease. Although polyvascular disease has long been associated with heightened cardiovascular risk, much is still unknown regarding its pathophysiology and management. In this past decade, the field of cardiovascular disease has experienced exponential growth in terms of antithrombotic and lipid-lowering therapies aimed at mitigating ischemic events. This review describes the inherent risk associated with polyvascular disease in contemporary observational and clinical trial populations and summarizes novel therapies in this high-risk population.<\/jats:p>","DOI":"10.1161\/circinterventions.119.007385","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T13:26:12Z","timestamp":1576243572000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":93,"title":["Polyvascular Disease"],"prefix":"10.1161","volume":"12","author":[{"given":"J. Antonio","family":"Gutierrez","sequence":"first","affiliation":[{"name":"Duke Heart Center, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (J.A.G., M.R.P., W.S.J.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron W.","family":"Aday","sequence":"additional","affiliation":[{"name":"Vanderbilt Translational and Clinical Cardiovascular Research Center, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN (A.W.A.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manesh R.","family":"Patel","sequence":"additional","affiliation":[{"name":"Duke Heart Center, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (J.A.G., M.R.P., W.S.J.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Schuyler","family":"Jones","sequence":"additional","affiliation":[{"name":"Duke Heart Center, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (J.A.G., M.R.P., W.S.J.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1322"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp099"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.19.2106"},{"key":"e_1_3_3_5_2","volume-title":"Vorapaxar reduces peripheral revascularization regardless of number of diseased territories: insights from the TRA2\u00b0P-TIMI 50 trial","author":"Bonaca MP","year":"2013","unstructured":"Bonaca, MP, Creager, MA, Olin, J, Scirica, BM, Bohula, EA, Murphy, SA, Braunwald, E, Morrow, DA.Vorapaxar reduces peripheral revascularization regardless of number of diseased territories: insights from the TRA2\u00b0P-TIMI 50 trial. San Francisco, California: American College of Cardiology Scientific Sessions; 2013."},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.03.524"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X18775594"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.5239"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2018.09.014"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.033898"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30290-0"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1615664"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.032235"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32409-1"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709118"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2009.05.006"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.303849"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-154-11-201106070-00003"},{"key":"e_1_3_3_19_2","first-page":"189","article-title":"The relationship of cigarette smoking to peripheral arterial disease.","volume":"5","author":"Lu JT","year":"2004","unstructured":"Lu, JT, Creager, MA. The relationship of cigarette smoking to peripheral arterial disease. Rev Cardiovasc Med. 2004;5:189\u2013193.","journal-title":"Rev Cardiovasc Med"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.719369"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.816181"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.035432"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.005077"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.11.1317"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2002.20307.x"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000471"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx095"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/clc.22713"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.117.003939"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000625"}],"container-title":["Circulation: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCINTERVENTIONS.119.007385","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T02:22:30Z","timestamp":1715566950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCINTERVENTIONS.119.007385"}},"subtitle":["Reappraisal of the Current Clinical Landscape"],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["10.1161\/CIRCINTERVENTIONS.119.007385"],"URL":"https:\/\/doi.org\/10.1161\/circinterventions.119.007385","relation":{},"ISSN":["1941-7640","1941-7632"],"issn-type":[{"value":"1941-7640","type":"print"},{"value":"1941-7632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"2019-12-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e007385"}}